Patients Coming Off Weight-Loss Jabs Gain Back Weight at a Quadrupled Rate Compared to People Using Diet and Exercise

Fresh analysis reveals that patients who come off popular weight-loss injections like Wegovy and Mounjaro may regain lost weight far faster than those who halt conventional diet and exercise programs.

Published data in a major medical journal points out that while overweight people can lose substantial amounts of their total mass while using the jabs, the mass is regained at an average rate of 0.8 kg per month upon discontinuation.

"Individuals using these drugs must be cognizant of the risk of quick weight regain when the treatment concludes," warns lead investigator Dr. Susan Jebb.

Such speed of recovery suggests a return to starting weight in about a year and a half.

Comparing Therapies

The analysis, which reviewed dozens of trials involving over 9,000 of participants, contrasted the outcomes of these new drugs with other pills.

Researchers emphasize that individuals who shed pounds through lifestyle changes alone generally have a less rapid creep back—perhaps 0.1 kg a month—once they finish.

The Reason for the Fast Regain

Experts suggest the mode of action of the jabs is key to understanding the amplified regain.

The injections imitate a natural hormone called GLP-1, which controls appetite.

"Sustained high doses of GLP-1 levels far above than the body's typical production could lead to the system to produce less of its endogenous GLP-1, and may also lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this hormone supplement leads to hunger is unsuppressed, making overeating a significant risk."

An Ongoing Issue?

Medical guidelines suggest the injections for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications.

A number of clinicians say that, given the significant potential of weight regain, the treatment is often life-long.

This perspective is reinforced by drug manufacturers, who state that the results "emphasize the chronic character of excess weight," akin to managing diseases like diabetes.

Patient Testimonies

Individuals who have stopped the jabs report a sudden return of appetite.

"I experienced a trigger flipping and you become ravenous," described a patient.

This challenge is compounded if users have not developed sustainable lifestyle or habit modifications during therapy.

Growing Interest

Survey data indicate that millions of adults in the UK have tried these injections in the last 12 months, with desire being substantial.

• Adoption is more common among females than men.
• The 40s and 50s demographic shows the highest level of interest.
• Many obtain the medications through private healthcare rather than the NHS.

Ultimately, clinicians stress that while these medications are effective agents for weight loss, they are not a magic cure and long-term success relies on ongoing behavioural changes.